Reply to M. Horiguchi et al Journal Article


Authors: Schadendorf, D.; Jiang, J.; Kelleher, T.; Postow, M. A.
Article Title: Reply to M. Horiguchi et al
Keywords: survival analysis; survival rate; overall survival; cancer combination chemotherapy; drug withdrawal; follow up; letter; ipilimumab; cancer immunotherapy; survival time; statistical analysis; nivolumab; human; priority journal
Journal Title: Journal of Clinical Oncology
Volume: 36
Issue: 7
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2018-03-01
Start Page: 721
Language: English
DOI: 10.1200/jco.2017.76.5339
PROVIDER: scopus
PUBMED: 29337639
DOI/URL:
Notes: Letter -- Export Date: 2 April 2018 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Michael Andrew Postow
    361 Postow